Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

17(S)-HpDHA

  • Zoom
    17(S)-<wbr/>HpDHA
  • 17(S)-<wbr/>HpDHA
Cat No: 13185
Biochemicals - Lipids
Cayman
€137.00
Price is excluding VAT and does not include packaging neither shipping

17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.{13989} 17(S)-HpDHA is generally reduced to 17(S)-HDHA (Item No. 10009799), a compound that serves as a precur...

More

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Technologies only in Europe
Synonyms:
  • 17S-hydroperoxy-4E,7Z,10Z,13Z,15Z,19Z-docosahexaenoic acid
Correlated keywords:
  • inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα 17(s)-hpdohe 17s-hdohe
Product Overview:
17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.{13989} 17(S)-HpDHA is generally reduced to 17(S)-HDHA (Item No. 10009799), a compound that serves as a precursor to 17(S)-resolvins. 17(S)-HDHA has been shown to inhibit TNF-α-induced interleukin-1β expression in human glioma cells and inhibit TNF-α-induced leukocyte trafficking to the murine air pouch.{13989}
Size 25 µg
Shipping dry ice
Stability Store at -80 degrees; shelf life 180 days
CAS Number 123673-33-6
Molecular Formula C22H32O4
SMILES CC\C=C/C[C@H](OO)/C=C/C=C\C\C=C/C\C=C/C\C=C/CCC(O)=O
Molecular Weight 360,5
Formulation A solution in ethanol
Purity ≥98%
Custom Code 2918.19
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : 17(S)-<wbr/>HpDHA There are 3 products.

Search